DE69413467T2 - Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie - Google Patents

Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie

Info

Publication number
DE69413467T2
DE69413467T2 DE69413467T DE69413467T DE69413467T2 DE 69413467 T2 DE69413467 T2 DE 69413467T2 DE 69413467 T DE69413467 T DE 69413467T DE 69413467 T DE69413467 T DE 69413467T DE 69413467 T2 DE69413467 T2 DE 69413467T2
Authority
DE
Germany
Prior art keywords
hepatopathy
remitting
agent
nephrotic syndrome
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413467T
Other languages
English (en)
Other versions
DE69413467D1 (de
Inventor
Guoji Ye
Jun-Ichi Kajihara
Sei Kirihara
Kazuo Kato
Hiroko Abe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JCR Pharmaceuticals Co Ltd
Original Assignee
JCR Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP19927593A external-priority patent/JP3161882B2/ja
Priority claimed from JP08587194A external-priority patent/JP3638967B2/ja
Application filed by JCR Pharmaceuticals Co Ltd filed Critical JCR Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of DE69413467D1 publication Critical patent/DE69413467D1/de
Publication of DE69413467T2 publication Critical patent/DE69413467T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69413467T 1993-07-15 1994-07-14 Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie Expired - Fee Related DE69413467T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19927593A JP3161882B2 (ja) 1993-06-03 1993-07-15 丹参由来多糖類、その製造法および用途
JP08587194A JP3638967B2 (ja) 1993-06-03 1994-03-30 ネフローゼ症候群及び肝障害症状の寛解剤

Publications (2)

Publication Number Publication Date
DE69413467D1 DE69413467D1 (de) 1998-10-29
DE69413467T2 true DE69413467T2 (de) 1999-06-10

Family

ID=26426874

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413467T Expired - Fee Related DE69413467T2 (de) 1993-07-15 1994-07-14 Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie

Country Status (9)

Country Link
US (1) US5547945A (de)
EP (1) EP0635519B1 (de)
KR (1) KR960013374A (de)
AT (1) ATE171462T1 (de)
AU (1) AU686161B2 (de)
CA (1) CA2127934A1 (de)
DE (1) DE69413467T2 (de)
FI (1) FI943242A (de)
RU (1) RU2119341C1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888366B1 (de) * 1996-03-21 2004-06-09 David Platt Modifiziertes pektinmaterial
WO1998024460A1 (en) * 1996-12-05 1998-06-11 Georgetown University Extracts of salvia species having antiviral activity
US6149915A (en) * 1999-09-29 2000-11-21 Shiva Biomedical, Llc Treatment of diabetic nephropathy and microalbuminuria
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005095463A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
PL2880160T3 (pl) 2012-08-03 2019-03-29 Cedars-Sinai Medical Center Izolowanie wzmacniających transport mutantów białka dostarczającego lek
US10881686B2 (en) 2017-10-27 2021-01-05 Zeta Biolongevity, Inc Compositions and methods for treating and preventing proteinuria and endothelial erosion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172831B (hu) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
JPH0753762B2 (ja) * 1986-10-03 1995-06-07 株式会社ツムラ 新規な多糖体

Also Published As

Publication number Publication date
RU2119341C1 (ru) 1998-09-27
FI943242A0 (fi) 1994-07-07
AU6747094A (en) 1995-01-27
FI943242A (fi) 1995-01-16
DE69413467D1 (de) 1998-10-29
EP0635519B1 (de) 1998-09-23
ATE171462T1 (de) 1998-10-15
AU686161B2 (en) 1998-02-05
CA2127934A1 (en) 1995-01-16
KR960013374A (ko) 1996-05-22
RU94026096A (ru) 1996-09-10
EP0635519A1 (de) 1995-01-25
US5547945A (en) 1996-08-20

Similar Documents

Publication Publication Date Title
Manners et al. The structure of a β-(1→ 6)-D-glucan from yeast cell walls
Christensen et al. Partial chemical and physical characterization of two extracellular polysaccharides produced by marine, periphytic Pseudomonas sp. strain NCMB 2021
Carlson Heterogeneity of Rhizobium lipopolysaccharides
Mourão et al. Structural features of sulfated glycans from the tunic of Styela plicata (Chordata‐Tunicata) A unique occurrence of L‐galactose in sulfated polysaccharides
Yamada et al. Purification of anti-ulcer polysaccharides from the roots of Bupleurum falcatum
McGarvie et al. Methylation analysis of the mucilage of Opuntia ficus-indica
Gao et al. Chemical properties and anti-complementary activities of polysaccharide fractions from roots and leaves of Panax ginseng
IL86881A (en) Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them
MISAKI et al. Studies on Cell Walls of Mycobacteria II. Constitution of Polysaccharides from BCG Cell Walls
AU648754B2 (en) Proanthocyanidol-based composition and its pharmacological application
Yagi et al. Structure determination of polysaccharides in Aloe arborescens var. natalensis
Heidelberger et al. Relations between structures of three K polysaccharides of Escherichia coli and cross-reactivity in antipneumococcal sera
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
DE69413467T2 (de) Polyglucuronsäure als remittierendes Mittel für das nephrotische Syndrom und Symptome von Hepatopathie
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
Yamada et al. Relationship between chemical structure and activating potencies of complement by an acidic polysaccharide, plantago-mucilage A, from the seed of Plantago asiatica
ES546783A0 (es) Procedimiento de preparacion de polisacaridos membranarios de origen bacteriano
McGarvie et al. The mucilage of Opuntia aurantiaca
Buchala et al. Hemicelluloses from the stalk of Cyperus papyrus
Zugibe Positive periodic acid-Schiff staining of acid mucopolysaccharides
Churms, SC*, Stephen, AM** & Van der Bijl Methylation and hydrolysis studies of a gum from Opuntia megacantha Lehmaniana
Smith et al. Polysaccharides leached from the surface of pea endocarp
Kiyohara et al. Pectic polysaccharide from roots of Glycyrrhiza uralensis: Possible contribution of neutral oligosaccharide in the galacturonase-resistant region to anti-complementary and mitogenic activities
Kato et al. Characterization of an acidic arabinoxylan from cell walls of immature barley plants
Christensen et al. Polysaccharide production by a marine, film-forming bacterium (Pseudomonas sp. NCMB 2021)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee